Ropivacaine bulk supplier for pharma manufacturers

Ropivacaine Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 0.2% (2 mg/mL), 0.5% (5 mg/mL), 0.75% (7.5 mg/mL), 1.0% (10 mg/mL)

Reference Brands: Naropin (US & EU)

Ropivacaine Hydrochloride is a long-acting local anesthetic used for epidural, spinal, and nerve block anesthesia. Available in 0.2% to 1.0% strengths, it offers effective pain control with reduced motor block and low cardiotoxicity. Ideal for B2B supply in the EU and US markets.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Ropivacaine Hydrochloride is a long-acting amide-type local anesthetic widely used in regional anesthesia, including epidural, spinal, and peripheral nerve blocks. Ideal for surgical and postoperative pain management, it offers effective sensory block with reduced motor impairment and lower cardiotoxicity than bupivacaine. In the pharma B2B market, Ropivacaine is available as API and injectable formulations in 0.2%, 0.5%, 0.75%, and 1.0% strengths. It complies with USP, EP, and BP standards, making it suitable for regulatory markets like the EU and US. Bulk supply, contract manufacturing, and private labeling options are available for hospitals, clinics, and distributors.

Ropivacaine — third party manufacturing & bulk supply

Ropivacaine is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ropivacaine is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ropivacaine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ropivacaine →

Back to Listing

Frequently Asked Questions

Ropivacaine is used as a local anesthetic for surgical anesthesia, postoperative pain management, and labor pain relief. It provides long-acting regional anesthesia suitable for epidural, spinal, and peripheral nerve block procedures.

Ropivacaine is made from the active ingredient Ropivacaine hydrochloride, an amide-type local anesthetic that works by blocking sodium channels in nerve cells, preventing the initiation and transmission of nerve impulses that cause pain.

The trade names of Ropivacaine include Naropin and Ropivacain Kabi.

Ropivacaine is manufactured by several pharmaceutical companies such as AstraZeneca, Fresenius Kabi, and Hikma Pharmaceuticals.

The generic name of Ropivacaine is Ropivacaine hydrochloride.

The brand names of Ropivacaine are Naropin and Ropivacain Kabi.

Ropivacaine is manufactured in Sweden, Germany, the United States, and several EU countries by GMP-certified facilities specializing in anesthetic formulations.